Viral Hepatitis

LONDON, UK, Aug 24, 2026 GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved...

Kirkland, Washington, August,11, 2026 EIT Pharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...

BASEL, Switzerland, July 14, 2026 Roche has introduced the cobas® Hepatitis D Virus (HDV) test, the first fully automated,...

BOSTON, July 14, 2026 Atea Pharmaceuticals announced the initiation of a first-in-human Phase 1 clinical trial evaluating AT-587, an...

North Chicago, Illinois, USA – May 22, 2026 AbbVie announced that the European Medicines Agency’s Committee for Medicinal Products...

Foster City, California, USA – May 21, 2026 Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration...

Foster City, California – October 20, 2025 — Gilead Sciences, Inc. (Nasdaq: GILD) announced that it will present new...